ATLANTA, GA – – (Globe Newswire – November 17, 2023) – – Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Kenvue Inc. (“Kenvue” or the “Company”) (NYSE: KVUE). The lawsuit alleges Kenvue made false or misleading statements and/or omitted material adverse information in the Registration Statement issued in connection with the Company’s May 2023 Initial Public Offering (“IPO”) regarding the Company’s business, operational and financial results, including allegations that: (1) Kenvue faces potential headwinds as a result of confirmed concerns about the efficacy of phenylephrine (or “PE”), which it knew or should have known; (2) Kenvue did not discuss risks relating to the efficacy of PE in its IPO, the utility of which had been questioned since at least 2007; and (3) while the Company disclosed risks relating to litigation, it did not disclose specific risk relating to potential litigation arising from adverse findings on the efficacy of PE.

If you bought Kenvue shares pursuant and/or traceable to the May 2023 IPO and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/kenvue/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is December 8, 2023.